-
EP2106259
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2106259
| EP2106259 - USE OF COMPOSITIONS COMPRISING AT LEAST ONE ALFA3 BETA4 NACHR ANTAGONIST SUCH AS MECAMYLAMINE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.02.2011 Database last updated on 15.06.2024 | Most recent event Tooltip | 04.02.2011 | Application deemed to be withdrawn | published on 09.03.2011 [2011/10] | Applicant(s) | For all designated states AGI Therapeutics Research Limited Adelaide Chambers Peter Street Dublin 8 / IE | [2009/41] | Inventor(s) | 01 /
DEVANE, John Heron Cove, Barrymore Athlone, Co. Roscommon / IE | [2009/41] | Representative(s) | MacLean, Martin Robert Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2009/41] | MacLean, Martin Robert Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB | Application number, filing date | 08737438.5 | 11.01.2008 | [2009/41] | WO2008IB00905 | Priority number, date | US20070698131 | 26.01.2007 Original published format: US 698131 | [2009/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008090471 | Date: | 31.07.2008 | Language: | EN | [2008/31] | Type: | A2 Application without search report | No.: | EP2106259 | Date: | 07.10.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.07.2008 takes the place of the publication of the European patent application. | [2009/41] | Search report(s) | International search report - published on: | EP | 27.11.2008 | Classification | IPC: | A61K31/13, A61K31/135, A61K31/14, A61K31/225, A61K31/34, A61K31/40, A61K31/445, A61K31/44, A61K31/47, A61K31/4965, A61K31/497, A61K31/56, A61K31/727, A61K33/24, A61K35/60 | [2009/41] | CPC: |
A61K45/06 (EP,US);
A61K31/13 (EP,US);
A61K31/135 (EP,US);
A61K31/14 (EP,US);
A61K31/225 (EP,US);
A61K31/34 (EP,US);
A61K31/40 (EP,US);
A61K31/415 (EP,US);
A61K31/44 (EP,US);
A61K31/445 (EP,US);
A61K31/47 (EP,US);
A61K31/4965 (EP,US);
A61K31/497 (EP,US);
A61K31/56 (EP,US);
A61K31/727 (EP,US);
A61K33/24 (EP,US);
A61K35/60 (EP,US);
A61K38/13 (EP,US);
A61P1/00 (EP);
A61P1/12 (EP);
A61P13/00 (EP);
| C-Set: |
A61K31/135, A61K2300/00 (US,EP);
A61K31/13, A61K2300/00 (US,EP);
A61K31/14, A61K2300/00 (US,EP);
A61K31/225, A61K2300/00 (US,EP);
A61K31/34, A61K2300/00 (US,EP);
A61K31/40, A61K2300/00 (US,EP);
A61K31/415, A61K2300/00 (US,EP);
A61K31/445, A61K2300/00 (US,EP);
A61K31/44, A61K2300/00 (US,EP);
A61K31/47, A61K2300/00 (EP,US);
A61K31/4965, A61K2300/00 (EP,US);
A61K31/497, A61K2300/00 (EP,US);
A61K31/56, A61K2300/00 (US,EP);
A61K31/727, A61K2300/00 (US,EP);
A61K33/24, A61K2300/00 (US,EP);
A61K35/60, A61K2300/00 (EP,US); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/41] | Title | German: | VERWENDUNG VON ZUSAMMENSETZUNGEN MIT MINDESTENS EINEM ALFA3-BETA4-NACHR-ANTAGONIST WIE ETWA MECAMYLAMIN ZUR BEHANDLUNG VON MAGEN-DARM-ERKRANKUNGEN | [2009/41] | English: | USE OF COMPOSITIONS COMPRISING AT LEAST ONE ALFA3 BETA4 NACHR ANTAGONIST SUCH AS MECAMYLAMINE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS | [2009/41] | French: | PROCÉDÉS ET COMPOSITIONS COMPRENANT AU MOINS UN ANTAGONISTE ALFA3 BÊTA4 NACHR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI | [2009/41] | Entry into regional phase | 31.03.2009 | National basic fee paid | 31.03.2009 | Designation fee(s) paid | 31.03.2009 | Examination fee paid | Examination procedure | 31.03.2009 | Amendment by applicant (claims and/or description) | 31.03.2009 | Examination requested [2009/41] | 22.09.2009 | Despatch of a communication from the examining division (Time limit: M04) | 28.01.2010 | Reply to a communication from the examining division | 10.05.2010 | Despatch of a communication from the examining division (Time limit: M04) | 21.09.2010 | Application deemed to be withdrawn, date of legal effect [2011/10] | 25.10.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/10] | Fees paid | Renewal fee | 25.01.2010 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2002016371 (SHYTLE DOUGLAS [US], et al) [X] 1-25,29-74,78,79 * paragraphs [0023] , [0004] * [Y] 26-28,75-77; | [XY]US2002016370 (SHYTLE DOUGLAS [US], et al) [X] 1-25,29-74,78,79 * paragraphs [0023] , [0004] *[Y] 26-28,75-77; | [XY]US2003199439 (SIMON DAVID LEW [US]) [X] 26-28,75-77 * paragraph [0031]; example 4 * * paragraph [0033]; claim - * [Y] 26-28,75-77; | [X]US2004209961 (DEVANE JOHN [IE]) [X] 1-79 * paragraph [0031]; claim - *; | [XY] - GARG K N, "Effects of mecamylamine and pempidine on the motility of small intestine in different species of animals", INDIAN JOURNAL OF MEDICAL RESEARCH,, (19661101), vol. 54, no. 11, ISSN 0971-5916, pages 1057 - 1059, XP009105700 [X] 1-25,29-74,78,79 * the whole document * [Y] 26-28,75-77 | [XY] - SUMMERS R W ET AL, "EFFECTS OF DRUGS, ILEAL OBSTRUCTION, AND IRRADIATION ON RAT GASTROINTESTINAL PROPULSION", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, (19700101), vol. 59, no. 5, ISSN 0016-5085, pages 731 - 739, XP009033303 [X] 1-25,29-74,78,79 * abstract * * page 737, column R, line 30 - page 738, column L, line 2 * [Y] 26-28,75-77 | by applicant | US2003199439 | - GARG, K. N., IND. JOUR. MED. RES., (1966), vol. 54, no. 11, pages 1057 - 1059 | - SUMMERS ET AL., GASTROENTEROLOGY, (1970), vol. 59, no. 5, pages 731 - 739 |